Last reviewed · How we verify
Study to Assess Artificial Intelligence-Assisted Insulin Titration System on Inpatients Glucose Control
This is a multi-center, open-labeled, parallel group, randomized controlled trial to access the effect and safety of the Artificial Intelligence Assisted Insulin Titration System (iNCDSS) in patients with Type 2 Diabetes Mellitus.
Details
| Lead sponsor | Shanghai Zhongshan Hospital |
|---|---|
| Phase | NA |
| Status | UNKNOWN |
| Enrolment | 120 |
| Start date | 2020-11-04 |
| Completion | 2021-12 |
Conditions
- Type 2 Diabetes
Interventions
- iNCDSS based insulin regime
- Physician based insulin regime
Primary outcomes
- Fasting plasma glucose of T2D patients — After 7-day intervention
Fasting plasma glucose of T2D patients by self-monitoring of bloodglucose (SMBG) in both groups
Countries
China